National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey

BACKGROUND: Evidence supporting nonstatin lipid‐lowering therapy in atherosclerotic cardiovascular disease risk reduction is variable. We aim to examine nonstatin utilization and expenditures in the United States between 2002 and 2013. METHODS AND RESULTS: We used the Medical Expenditure Panel Surve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Salami, Joseph A., Warraich, Haider J., Valero‐Elizondo, Javier, Spatz, Erica S., Desai, Nihar R., Rana, Jamal S., Virani, Salim S., Blankstein, Ron, Khera, Amit, Blaha, Michael J., Blumenthal, Roger S., Katzen, Barry T., Lloyd‐Jones, Donald, Krumholz, Harlan M., Nasir, Khurram
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850149/
https://ncbi.nlm.nih.gov/pubmed/29358195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007132
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars